It has been shown that mTICI 2b to 3 is an accurate predictor of functional independence and also a pivotal biomarker for comparing the efficacy of different techniques Background and Purpose-The modified Treatment In Cerebral Ischemia (mTICI) score is the standard method to quantify the degree of reperfusion after endovascular treatment in acute ischemic stroke. In clinical practice, it is commonly assessed by local operators after the procedure. In clinical trials and registries, mTICI is evaluated by an imaging core lab. The aim of this study was to compare operator mTICI with core lab mTICI scores in patients included in the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Registry. Methods-All patients with an intracranial carotid or middle cerebral artery occlusion with anteroposterior and lateral digital subtraction angiography runs were included. Operators determined the mTICI score immediately after endovascular treatment. Core lab neuroradiologists were blinded to clinical characteristics and assessed mTICI scores based on preand postintervention digital subtraction angiography. The agreement between operator and core lab mTICI scores and their value in the prediction of outcome (score on modified Rankin Scale at 90 days) was determined. Results-In total, 1130 patients were included. The proportion of agreement between operator and core lab mTICI score was 56% (95% CI, 54%-59%). In 33% (95% CI, 31%-36%), mTICI was overestimated by operators. Operators reported a higher rate of successful reperfusion than the core lab (77% versus 67%; difference 10% [95% CI, 6%-14%]; P<0.001).
ndovascular thrombectomy (EVT) has become standard care for patients with acute ischemic stroke caused by large vessel occlusion in the anterior circulation. [1] [2] [3] [4] [5] Estimation of reperfusion in patients who undergo EVT is a means to evaluate the immediate effect of therapy and is strongly associated with outcome. To quantify the degree of reperfusion, the modified Treatment in Cerebral Ischemia (mTICI) score is widely applied. 6 Its categories span from no reperfusion (grade 0) to complete reperfusion (grade 3), and mTICI 2b to 3 is considered successful reperfusion after EVT in acute ischemic stroke trials. or devices. 7, 8 In clinical practice, mTICI score is commonly assessed by operators after EVT. In major clinical trials and some registries, mTICI score assessment is also performed by imaging core laboratories. 9 Core lab assessment is considered as gold standard because of its rigor. It remains unclear to what degree operator bias exists in the estimation of mTICI. In particular, operators may tend to overestimate mTICI score because they evaluate their own work. Such an overestimation could lead to unreliable results in studies without core lab adjudication of reperfusion.
The aim of this study was to compare operator mTICI with core lab mTICI scores to gain an insight into the agreement between the operator and core lab mTICI score assessment.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
All patients undergoing EVT (defined as entry into the angiography suite and undergoing arterial puncture) for acute ischemic stroke from March 16, 2014 , to June 15, 2016 , in the 16 MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) centers in the Netherlands have been registered in the MR CLEAN Registry. The MR CLEAN Registry is a prospective national multicenter registry of all patients with acute ischemic stroke who underwent EVT (defined as entry into the angiography suite and undergoing arterial puncture) after the MR CLEAN, with core lab evaluation of all imaging data. 10 The MR CLEAN Registry was approved by the ethics committee of the Erasmus University Medical Center, Rotterdam, the Netherlands (MEC-2014-235) and therefore by the research board of each participating center. At the University Medical Center Utrecht, approval to participate in the study was obtained from their own research board and ethics committee.
Only patients with an intracranial carotid artery or middle cerebral artery (M1, M2, M3) occlusion demonstrated by computed tomographic angiography with both anteroposterior and lateral digital subtraction angiography (DSA) runs were included in this post hoc analysis.
mTICI Score Assessment
The mTICI was scored as follows 11 : grade 0, no perfusion; grade 1, antegrade reperfusion past the initial occlusion, but limited distal branch filling with little or slow distal reperfusion; grade 2a, antegrade reperfusion of less than half of the downstream vascular territory; grade 2b, antegrade reperfusion of half or more (but less than complete) of the downstream vascular territory; grade 3, complete antegrade reperfusion of the downstream vascular territory, with absence of visualized occlusion in all distal branches. Successful reperfusion was defined as mTICI 2b to 3.
Local operators from the 16 intervention centers determined the mTICI score using a standard case report form directly after the procedure. The core lab (consisting of 8 experienced neuroradiologists who were blinded to clinical characteristics) assessed pre-and postintervention DSA mTICI scores using a similar case report form.
Outcome Measures
Functional outcome was determined at ≈90 days after treatment with the modified Rankin Scale (mRS), which ranges from 0 no symptoms to 6 death. Functional independence was defined as an mRS score of 0 to 2.
Statistical Analysis
To assess agreement, the proportion of agreement between operator and core lab mTICI with its 95% CI determined with Wilson score method was assessed. 12 The association of both operator and core lab mTICI with functional outcome was assessed with multivariable ordinal logistic regression (shift analysis) adjusted for age, sex, baseline National Institutes of Health Stroke Scale, prestroke mRS, Alberta Stroke Program Early CT Score, collateral status, use of intravenous thrombolysis, and the time from onset to reperfusion and expressed as an adjusted common odds ratio (OR) for a shift on the mRS toward good outcome. Multivariable binary logistic regression (with adjustment for the same variables) was used to determine the association between successful reperfusion and functional independence. The association was expressed with an adjusted OR. To estimate the difference between operator and core lab adjudication of successful reperfusion, the χ 2 test was used to estimate the difference between operator and core lab adjudication of successful reperfusion. The C statistic was estimated to compare the discriminatory power of core lab and operator scored successful reperfusion for full-scale outcome and functional independence. All analyses were performed using Empower (R) (http://www. 
Missing Data
For more precise effect estimation with logistic regression, multiple imputation for missing data was performed with the Hmisc package in R (v4.1-1). The following variables were used for imputation: operator and core lab mTICI score, mRS, age, sex, baseline National Institutes of Health Stroke Scale score, glucose level, collateral status, diabetes mellitus, hypertension, previous myocardial infarction, previous stroke, pre-mRS, hypercholesterolemia, atrial fibrillation, peripheral arterial disease, smoking, medication use (antiplatelets, statins, anticoagulants, and antihypertensives), use of intravenous thrombolysis, if transferred from other hospital, blood pressure, baseline Alberta Stroke Program Early CT Score, occlusion location, thrombocyte, type of anesthesia, international normalized ratio, time from symptom onset to start of EVT, time from onset to computed tomographic scan, time from symptom onset to successful reperfusion or last contrast bolus, and National Institutes of Health Stroke Scale score after 24 to 48 hours. Data after imputation were only used for the regression analyses and not for the descriptive analyses.
Results
In the MR CLEAN Registry, 1628 patients were registered between the March 16, 2014, and the June 15, 2016. For the current analysis, 328 patients were excluded because of an occlusion of the posterior circulation, M4 or anterior cerebral artery occlusion or missing lateral DSA images (see Figure I in the online-only Data Supplement). A total of 1300 patient with complete lateral and anteroposterior DSA runs after EVT were included. Of these 1300 patients, the mean age was 68.6±14.5 years and 598 (46.0%) were women. In 695 (53.5%) patients, occlusions were located in the left hemisphere. Occlusions on initial vessel imaging involved intracranial carotid artery in 252 (21.0%) patients, M1 in 660 (54.9%) patients, M2 in 224 (18.6%), and M3 in 31(2.6%) patients. Thirty-five patients with occlusions demonstrated by computed tomographic angiography but without occlusion on DSA imaging were also included. The median admission National Institutes of Health Stroke Scale score was 16 (interquartile range, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Nine hundred ninety-nine (76.8%) patients received intravenous alteplase therapy before EVT. The mean time from stroke onset to groin puncture was 222±87 minutes. Further baseline characteristics of all included patients are presented in Table 1 . In 118 of 1300 (9%) of patients, either an operator or core lab mTICI score was missing. Functional outcome was missing for 8.2% of patients. The mean percentage of missing variables for the baseline characteristics ranged from 0% to 32.8% (mean, 4.2%).
Distribution of mTICI in MR CLEAN Registry
In 1182 patients, mTICI scores assessed by both operator and core lab were available ( Figure I in the online-only Data Supplement). The distribution of operator and core lab mTICI score is shown in Figure 1 . According to the operator assessment, a total of 916 of 1182 (77%) patients were scored as successful reperfusion; 46.3% of these patients achieved functional independence at 90 days. Core lab adjudication revealed that successful reperfusion was scored in 796 of 1182 (67%) patients; 48.1% of these patients achieved functional independence. Operators reported a higher rate of successful reperfusion than the core lab (77% versus 67%; difference 10% [95% CI, 6%-14%]; P<0.001).
Disagreement Between Operator and Core Lab mTICI
The overall proportion of agreement between operator and core lab mTICI scores was 56% (95% CI, 54%-59%). In 33% (95% CI, 31%-36%), the mTICI score was overestimated by operators compared with core lab assessment and in 10% (95% CI, 9%-12%) underestimated. Of the 386 patients with core lab scores 0 to 2a, 158 (41%) were overestimated to 2b to 3 by the local operator. Furthermore, in 252 (33%) of the 763 patients where the core lab scored incomplete reperfusion (mTICI <3), the local score was mTICI 3. The percentage of operator's overestimation was 28% (40 of 143) for score 0, 65% (22 of 34) for 1, 64% (134 of 209) for 2a, and 52% (198 of 377) for 2b ( Figure 2) . Overestimation was more common in patients with M2 and M3 occlusions (40% and 43%, respectively, compared with 31% and 34% for intracranial carotid artery and M1).
Prediction of Clinical Outcome: Operator Versus Core Lab mTICI
The distribution of mRS for each mTICI grade was shown in Figure 3 . The proportion of functional independence was similar in patients with operator and core lab successful reperfusion scores (46.3% versus 48.1%; P=0.482). In patients with successful reperfusion scored by the local operator but a core lab mTICI score of 0 to 2a, the proportion of functional independence was 34% (51 of 151). However, this proportion in patients with both operator and core lab mTICI 2b to 3 was 49% (334 of 680).
Successful reperfusion assessed by the operator was associated with outcome both on full-scale mRS (adjusted common OR, 3 achieve functional independence (adjusted OR, 3.54 [95% CI, 2.58-4.86]). Multivariable logistic regression models containing either core lab scored successful reperfusion or operator scored successful reperfusion predicted outcome (C statistic of both models: 0.76) and functional independence (C statistic of both models: 0.83) equally well ( Table 2 ).
Discussion
This study shows that substantial disagreement exists between the assessment of the degree of reperfusion by local operators and the independent core lab of the MR CLEAN Registry. In general, the operator scores were higher than core lab scores. In addition, mTICI scores were more likely to be 
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There is some disagreement within the literature on the reliability of angiographic reperfusion grading. Previous studies have shown good inter-and intrarater agreement for the mTICI score. 13, 14 However, this study confirms the findings reported in the SWIFT trial (SOLITAIRE With the Intention for Thrombectomy), where substantial reperfusion was scored more often by the study site compared with the core lab in both the Solitaire arm and the Merci arm. 15 Our results are also in line with studies from other disciplines. Alhadramy et al 16 found a significant discrepancy between the operator and core lab assessments of the Thrombolysis in Myocardial Infarction scale, used to determine reperfusion after coronary angioplasty. The disagreement between operator and core lab was also observed in the evaluation of endovascular treatment outcomes of intracranial aneurysms. 17 In our study, the proportion of successful reperfusion scored by the operator exceeded the core lab assessment by 10%. This overestimation of mTICI could be of clinical relevance because it may cause procedures to be terminated prematurely. Operators may terminate the procedure without additional effort to optimize recanalization after they overestimate reperfusion. Furthermore, in recent studies without core lab evaluation, reported proportion of successful reperfusion may be too high because of the bias of local operator mTICI estimation. 18 As previous studies have shown, the rate of functional independence is different for each mTICI score. 19, 20 In previous studies, in the mTICI 3 group, 60% to 70% of patients reached functional independence while these rates were 45% to 55% and 15% to 35% for mTICI 2b and 2a, respectively. 21, 22 This suggests that an overestimation of the reperfusion rate may lead to overestimation of the probability of functional independence. In our population, functional independence rates for core lab mTICI 3, 2b, and 2a were 53%, 43%, and 29%, respectively. These lower rates compared with previous studies could reflect the broader inclusion criteria of the MR CLEAN Registry. 10 Rates of functional independence in operator assessment were only slightly lower (2%-6%) for each operator mTICI grade compared with the core lab. Furthermore, clinical outcome prediction of the 2b to 3 score of the operators was also similar to that of the core lab. Therefore, one could conclude that the value of the core lab in registries might be limited. Last, in clinical trials investigating the relative superiority of a device or technique with technical success as primary outcome, blinded assessment is mandatory to achieve reliable results.
Although the majority of the occlusions are located in intracranial carotid artery and M1 in this study, we found that mTICI in patients with an M2 or M3 occlusion were more likely to be overestimated by operators. The increased operator overestimation of reperfusion in distal occlusions may be because of the greater difficulty of assessing the territory at risk because of overprojection of other branches. Operators should be more cautious when estimating mTICI score in M2 and M3 occlusions.
The strengths of our study are the use of large consecutive and prospectively collected patient cohort with acute ischemic stroke because of large vessel occlusion, treated with EVT and the use of standard case report form to assess the reperfusion by local operators and core lab members.
This study is limited by the lack of interrater variability assessments of mTICI scores by members of the core lab. However, we thought the good interrater agreement within core lab members 13, 14 found in previous studies justified the adjudication of 1 mTICI score per patient by 1 experienced neuroradiologist. The study may also be limited by the small sample of unsuccessful reperfusion (only 33% in the core lab adjudication). In addition, mTICI score with 2c category is widely used in recent studies. However, we did not use it in this study. 23 First, because we started the registry in 2014, mTICI 2C was not common at that time. Second, previous studies showed mTICI 2C category may not have sufficient interrater reliability for use in clinical practice. 19, 24 In our opinion, the original mTICI score may, therefore, be more rational for operator assessment.
Conclusions
Our findings show that operators tend to overestimate achieved reperfusion after endovascular treatment compared with assessment by a core lab although this overestimation does not affect the association with outcome. Local principal investigators: Wouter J. Schonewille, 7 Jan Albert 
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